ResMed RMD Business Segments
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Business | ||||||
| Residential Care Software | $170.89M+6.0% | $166.87M+6.6% | $166.14M+6.0% | $167.01M+9.9% | $161.16M+8.9% | |
| Sleep and Breathing Health | $1.26B+11.5% | $1.26B+11.6% | $1.17B+9.5% | $1.18B+10.2% | $1.13B+7.8% | |
| Net revenue by segment by Product | ||||||
| Devices | $1.47B+8.8% | $1.45B+8.5% | $1.36B+8.7% | —— | $1.35B+6.0% | |
| Masks and other | $1.05B+15.5% | $1.06B+16.1% | $978.27M+10.7% | —— | $908.74M+10.6% | |
| Residential Care Software | $170.89M+6.0% | $166.87M+6.6% | $166.14M+6.0% | $167.01M+9.9% | $161.16M+8.9% | |
| Sleep And Breathing Health | $1.26B+11.5% | $1.26B+11.6% | $1.17B+9.5% | $1.18B+10.2% | $1.13B+7.8% | |
| Net revenue by segment by Geography | ||||||
| Combined Europe, Asia and other markets | $441.84M+15.9% | $420.91M+11.8% | $394.69M+9.5% | $389.04M+13.1% | $381.26M+5.5% | |
| Global revenue | $1.43B+10.8% | $1.42B+11.0% | $1.34B+9.1% | —— | $1.29B+7.9% | |
| U.S., Canada and Latin America | $818.67M+9.3% | $835.03M+11.5% | $774.75M+9.5% | —— | $749.32M+9.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ResMed break its business down?
- ResMed (RMD) reports net revenue by business across 2 parts — Residential Care Software and Sleep and Breathing Health. Each is extracted from the segment footnotes and tracked over time.
- Where does ResMed's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ResMed's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
